EXENS — Exosens SAS Income Statement
0.000.00%
- €4.21bn
- €4.51bn
- €291.82m
Annual income statement for Exosens SAS, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 150 | 166 | 201 | 292 |
Cost of Revenue | ||||
Gross Profit | 114 | 123 | 145 | 216 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 120 | 281 | 173 | 244 |
Operating Profit | 30 | -114 | 27.8 | 48.3 |
Total Net Non Operating Interest Income / Expense | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -13.2 | -150 | 17.1 | 20.2 |
Provision for Income Taxes | ||||
Net Income After Taxes | -15.8 | -149 | 11.2 | 18.4 |
Net Income Before Extraordinary Items | ||||
Net Income | -15.8 | -149 | 11.2 | 18.4 |
Adjustments to Net Income | ||||
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -15.8 | -149 | 11.2 | 18.4 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.153 | -0.429 | 0.011 | 0.106 |